Momenta Pharmaceuticals, Inc. (MNTA)

zversyp (< 20) Submitted: 2/05/08 6:18 PM : Start Price: $9.60 MNTA Score: 80.86

This company has a lot of potential. They have a fairly decent pipeline of drugs, along with a good partnership with Sandoz. They have one drug candidate awaiting approval by the FDA, and another in Phase 2 trails. They also have several other can...

Report this Post Replies: 0 | Reply | Permalink

NetscribeHealthC (70.24) Submitted: 3/19/07 2:45 AM : Start Price: $12.48 MNTA Score: 36.62

Momenta focuses on the sequencing of complex sugars for development of generic versions of existing drugs and the discovery and development of novel drugs. The company's follow-on products include M-enoxaparin and M-dalteparin and its one novel pipel...

Report this Post Replies: 2 | Reply | Permalink

TMFBreakerThiel (< 20) Submitted: 8/18/06 6:16 PM : Start Price: $15.35 MNTA Score: 6.84

Profits in sugar chemistry? Sweeeeeeet. Being the sole generic alternative to the $2.7 billion Lovenox will put this one through the roof. But first they must navigate the impenetrable labyrinth of FDA regulation, before the evil Amphastar or Teva. O...

Report this Post Replies: 0 | Reply | Permalink

zzlangerhans (91.05) Submitted: 2/29/08 11:40 AM : Start Price: $10.22 MNTA Score: -62.10

Everyone is wondering why Momenta is jumping up on no news on a day the broad market is eating sh-t. All they need to do is look at CAPS and see that I ended my outperform two days ago after several quiet months - ergo an immediate 30% gap up. So I'm...

Report this Post Replies: 1 | Reply | Permalink

KatWoman50 (95.56) Submitted: 11/06/07 3:04 PM : Start Price: $6.02 MNTA Score: 181.70

Attempting to catch a falling knife. Momenta has a lot more in the pipeline than just M-enoxaparin and should bounce when the over-reaction is finished. 160M cash should tide them over for awhile even without further investment.

Report this Post Replies: 1 | Reply | Permalink

Ganndalf (< 20) Submitted: 6/14/07 11:49 AM : Start Price: $15.88 MNTA Score: 11.00

Honestly, I know precious little about Momenta, but here's a few things I do know:

They are very close to their 52-week low right now, which more often than not can be a good sign of a bargain buy.

Looks like a waiting game for its lead compound ri...

Report this Post Replies: 0 | Reply | Permalink

rsgtomc (< 20) Submitted: 3/02/07 3:28 AM : Start Price: $11.83 MNTA Score: 44.21

MNTA has a excellent business plan for capturing a generic drug market of blockbuster drugs as sole generic provider. Their exclusive patented methods for analysing very complex compounds sets them apart from the competition in proving bioequivalenc...

Report this Post Replies: 0 | Reply | Permalink

PBrigg (94.48) Submitted: 6/27/07 2:01 PM : Start Price: $11.32 MNTA Score: 56.07

Why is this stock so low?!?! Way undervalued currently. Once they get FDA approval this stock is gonna be rockin. Definitely outperforming the S&P.

Report this Post Replies: 0 | Reply | Permalink

fool4dance (49.04) Submitted: 3/16/07 10:22 AM : Start Price: $19.21 MNTA Score: -5.34

I think Momenta has finally bounced. Litigation is going its way and I've finally jumped in with real $.

Report this Post Replies: 0 | Reply | Permalink

jphirsch (23.92) Submitted: 4/17/07 10:31 PM : Start Price: $15.42 MNTA Score: 16.69

Was brought down by a legal decision which was actually somewhat in their favor. Additionally, waiting on FDA ruling, which could seriously boost the stock. Finally, if that fails - then they are developing new drugs in addition with this same propri...

Report this Post Replies: 0 | Reply | Permalink